Trial NCT04379518

View at ClinicalTrials.gov 
Org. Study IDs: I 659920
Secondary IDs: I 659920 NCI-2020-02317 P30CA016056

Last trial update was posted on 2023-03-06

MeSH Interventions

Interferon alpha-2 Interferon-alpha Interferons poly(I).poly(c12,U)

MeSH Conditions

COVID-19 Laboratory Infection Neoplasms

Other Conditions

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Symptomatic COVID-19 Infection Laboratory-Confirmed

Stopping Reasons

working on revision to protocol

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID